Navigation Links
Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis
Date:11/27/2012

LEXINGTON, Mass., Nov. 27, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the digestive tract, announced today that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AVX-470 for the treatment of ulcerative colitis. AVX-470 is an anti-TNF polyclonal antibody and is the first clinical candidate to come from Avaxia's oral antibody platform. The Company expects to initiate a Phase 1b clinical trial of AVX-470 in patients with active ulcerative colitis in the near term.

"Clearance of the IND allows us to advance AVX-470 into clinical development, which furthers our goal of providing patients afflicted with inflammatory bowel disease with a promising new treatment option," stated Barbara S. Fox, CEO of Avaxia. "Because AVX-470 is delivered directly to the GI tract, it has a lower potential for systemic immunosuppression than injectable anti-TNF therapies while potentially retaining the proven benefits of anti-TNF antibody therapy for inflammatory bowel disease."

About AVX-470

Avaxia has created a technology platform and a broad patent portfolio around orally administered antibodies that affect targets in the digestive tract. AVX-470 is the first product from Avaxia's platform to reach clinical development. AVX-470 is a bovine polyclonal antibody to tumor necrosis factor (TNF), a pro-inflammatory protein that has been implicated in inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. Today, injectable anti-TNF antibodies are used as an effective treatment for many IBD patients, with about $2.5 billion in sales in 2011. However, as injected drugs, they suppress the immune system throughout the body, not just locally in the gastrointestinal (GI) tract, where the disease occurs. The potentially serious side effects resulting from this systemic immunosuppression warrant a "
'/>"/>

SOURCE Avaxia Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
2. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
3. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
4. Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities
5. Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
6. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
7. South and Central America Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
8. CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement with Innomedica
9. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
10. CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
11. Brazil Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015  AMRI (NASDAQ: AMRI ) ... collaboration focused on the development, manufacture and marketing ... ("APIs"). The collaboration combines Saneca,s strength in extracting ... developing and manufacturing controlled substance APIs with AMRI,s ... processes into these facilities. The collaboration will also ...
(Date:8/31/2015)... Vascular Ltd., together with its subsidiaries (the "Company" ... the "Group"), a global company engaged in the ... for the minimally invasive treatment of vascular disease, ... ("BTK") cohort of patients in the Chocolate® Balloon ... 15, 2015 at the 5th Annual Amputation Prevention ...
(Date:8/30/2015)... 31, 2015 Noser Health ... to deliver new platform ... citizen-owned health data transaction platform, announced today strategic partnerships ... to engineer and bring to market its global health ... "Our business model is built on trust, ...
Breaking Medicine Technology:AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4
... 30 AstraZeneca (NYSE:,AZN) today announced that it ... U.S. Food and Drug Administration (FDA) for approval ... Aerosol for the treatment of patients with Chronic ... the long-term,maintenance treatment of asthma in patients 12 ...
... Naval Medical Center, George Mason, University Study ... to Baseline Measures and Ongoing ,Surveillance, Model for ... Management of Common, Debilitating Condition, BETHESDA, Md., ... patients for subclinical lymphedema enables clinicians to,establish a ...
Cached Medicine Technology:AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 2AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 3AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 4AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication 5Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema 2Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema 3
(Date:8/31/2015)... California (PRWEB) , ... August 31, 2015 , ... ... by host/actor/writer/director/ CSUN psychology professor Luciana Lagana (aka Dr. Luciana) received a ... for Best Web Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote ...
(Date:8/31/2015)... ... August 31, 2015 , ... Wyoming Medical Center, an ... for its Clinical Documentation Improvement (CDI) and medical coding needs. Based on a ... - ezCAC is an enterprise-level coding solution that combines CDI, Coding, Quality and ...
(Date:8/31/2015)... , ... August 31, 2015 , ... With baseball season ... and the World Series will dominate the sports world. Fans desire nothing more than ... to the final series. For children, especially those who are too young to really ...
(Date:8/31/2015)... ... 31, 2015 , ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored ... in Mendon, IL. The purpose behind this concert was to raise money for music ... Best Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with a portion of ...
(Date:8/31/2015)... ... 31, 2015 , ... In preparation for this November’s National Family Caregivers Month, ... sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” The information ... a variety of home healthcare challenges, specifically as they relate to caring for the ...
Breaking Medicine News(10 mins):Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... that a specialized virus with the ability to reproduce its ... mice and eliminate them. Healthy brain tissue remained virtually untouched, ... of Neuroscience . With more research, the technique could one ... humans. , Most importantly, this study finds that the virus ...
... 19 Accenx Technologies, Inc., a,leading company in ... integration solutions, announced today the launch of their,new ... to their,clients, such as large health systems, hospitals, ... physician outreach programs, and connect,physician practices to RyTRAK ...
... the daughter of,Virginia Kent, Deceased, seeks vindication in ... which was caused by the prescription drug,Rezulin. Michigan,s ... All Rezulin cases in the United States ... 187 cases from Michigan. All Michigan,cases were dismissed ...
... North American Insurance,Leaders, Inc. (Amex: NAO ) ("NAIL"), ... time to consider and vote on the proposed,acquisition of ... of,additional proxies related thereto, its annual meeting of stockholders,originally ... 2:00 p.m. local,time, has been postponed and will now ...
... cold winter day and you will see the water vapor ... a Nobel-Prize-related tool, and you could potentially detect trace amounts ... signs of disease. In a new paper,* a team led ... of the National Institute of Standards and Technology (NIST) and ...
... development of new technologies that demand a,highly-trained workforce and ... provide the backdrop for this historic,undertaking by the nation,s ... a march, rally and press conference on,Wednesday, Feb. 20 ... gather at the Main Entrance to Summit,Medical Center, 350 ...
Cached Medicine News:Health News:Tumor-killing virus selectively targets diseased brain cells 2Health News:New Accenx Physician's Relations Department! Now At Your Service 2Health News:Michigan Resident, Kimberly Kent's Drug Product Liability Case Will Be Argued in the United States Supreme Court on February 25, 2008 2Health News:North American Insurance Leaders, Inc. Postpones Stockholders Meeting 2Health News:Optical 'frequency comb' can detect the breath of disease 2Health News:UHW Kicks Off Contract Campaigns for 75,000 Hospital and Nursing Home Workers in Unprecedented Effort to Raise Quality Statewide 2
... true breakthrough in ophthalmic ultrasound, offering an ... capability previously unavailable. See pathology formerly unavailable, ... up to 105db to view vitreous details ... 90db setting - or reduce it to ...
The Ultrasonic BioMicroscope (UBM P40) provides the highest ultrasound resolution for imaging....
PremierEdge Stab Knives - 45....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: